Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
SITE Centers
SITC
$236M
| $55.3M | 0.03% |
5,200,426
-1,230,264
| -19% | -$12.3M |
|
352
Piper Sandler
PIPR
$4.99B
| $55.1M | 0.03% |
1,260,532
-87,964
| -7% | -$3.35M |
|
353
Churchill Downs
CHDN
$6.17B
| $54.7M | 0.03% |
405,694
-940
| -0.2% | -$112K |
|
354
Crown Castle
CCI
$34.6B
| $54.3M | 0.03% |
471,161
-5,019
| -1% | -$514K |
|
|
PCH
355
DELISTED
PotlatchDeltic
PCH
| $54.2M | 0.03% |
1,104,622
+106,608
| +11% | +$4.88M |
|
356
Jabil
JBL
$30.1B
| $54.1M | 0.03% |
424,299
-159,466
| -27% | -$20.3M |
|
357
Lattice Semiconductor
LSCC
$16B
| $53.7M | 0.03% |
778,346
+195,604
| +34% | +$13M |
|
358
Academy Sports + Outdoors
ASO
$3.04B
| $53.7M | 0.03% |
813,389
+106
| +0% | +$5.38K |
|
359
M/I Homes
MHO
$3.95B
| $53.7M | 0.03% |
389,562
+1,111
| +0.3% | +$111K |
|
360
SPX Corp
SPXC
$9.39B
| $53.5M | 0.03% |
529,963
+15,118
| +3% | +$1.31M |
|
361
Royalty Pharma
RPRX
$26.2B
| $53.4M | 0.03% |
1,900,614
-335,782
| -15% | -$9.23M |
|
362
Alnylam Pharmaceuticals
ALNY
$38.3B
| $53.2M | 0.03% |
278,081
-15,409
| -5% | -$2.62M |
|
363
UDR
UDR
$12.9B
| $53.1M | 0.03% |
1,387,043
-448,354
| -24% | -$15.6M |
|
364
Fortune Brands Innovations
FBIN
$5.86B
| $52.7M | 0.03% |
692,786
-38,747
| -5% | -$2.55M |
|
365
Doximity
DOCS
$3.89B
| $52M | 0.03% |
1,853,105
+239,238
| +15% | +$5.65M |
|
366
Vanguard FTSE Europe ETF
VGK
$30.1B
| $51.8M | 0.03% |
803,735
+596,866
| +289% | +$35.7M |
|
367
Grocery Outlet
GO
$904M
| $51.1M | 0.03% |
1,896,381
+205,773
| +12% | +$5.77M |
|
|
WIRE
368
DELISTED
Encore Wire Corp
WIRE
| $51M | 0.03% |
238,684
-36,199
| -13% | -$6.89M |
|
369
Franklin FTSE United Kingdom ETF
FLGB
$897M
| $51M | 0.03% |
2,026,449
-53,476
| -3% | -$1.29M |
|
370
Signet Jewelers
SIG
$3.84B
| $50.9M | 0.03% |
474,798
+454,617
| +2,253% | +$37.3M |
|
371
Healthpeak Properties
DOC
$15.5B
| $50.8M | 0.03% |
2,568,692
-930,316
| -27% | -$16.4M |
|
|
MRO
372
DELISTED
Marathon Oil Corporation
MRO
| $50.8M | 0.03% |
2,104,455
-81,013
| -4% | -$2.09M |
|
373
Vestis
VSTS
$1.97B
| $50.4M | 0.03% |
+2,386,115
| New | +$41M |
|
374
Ametek
AME
$53.9B
| $50.3M | 0.03% |
305,125
-14,596
| -5% | -$2.23M |
|
|
PXD
375
DELISTED
Pioneer Natural Resource Co.
PXD
| $50.3M | 0.03% |
223,604
-548,538
| -71% | -$129M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.